Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation



When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

DIA 2017

When, where, and how? Experts examine the current state of Brexit

13-Jul-2017 - The pharmaceutical industry and regulators are preparing for Brexit and how to best “manage and mitigate” any potential risks the UK’s departure from the EU may pose.

CRO market in Asia to see 'significant increase' through 2020

06-Mar-2017 - The CRO market in Asia has “massive implications” as it continues to emerge as a preferred destination for clinical trials – a global market expected to reach $57bn by 2020.

Quartesian hiring 100 employees in 2017 as it expands globally

02-Mar-2017 - Quartesian is opening new and expanded offices in Bangalore and Chennai, India and Kiev, Ukraine to help support its plans to double bookings in 2017.

Clinerion aims for 50m patients by Q2 2017 as it enters South America

10-Jan-2017 - iHealth Group of Brazil has joined Clinerion’s Patient Recruitment System platform as its first installation in South America while the company looks to expand in other developing markets in 2017.

Almac announces £27m global expansion

11-Nov-2016 - The Almac Group is planning to expand its operations in Europe and North America with an investment totaling £27m across three sites.

CFDA: reports of clinical trial data fraud 'not fact based'

25-Oct-2016 - The Chinese Food and Drug Administration (CDFA) has fired back on lack of context in media reporting “80% of China’s clinical trial data are fraudulent.”

Worldwide Clinical Trials opens new facility in Poland

26-Sep-2016 - The 315 square meter facility will house more than 30 employees in Warsaw, Poland, where the company contract research organization (CRO) has operated since 2008.

iCardiac collaborating with Japanese SMO to conduct cardiac safety studies

19-Sep-2016 - iCardiac Technologies and SNBL CPC Japan, a Japanese-based Site Management Organization (SMO), will collaborate on cardiac safety studies in the country.

Marken expands capabilities with new pharma license at Moscow depot

24-Aug-2016 - Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.

Ash Stevens acquired by India-based CDMO

16-Aug-2016 - Ash Stevens has been acquired by Piramal Pharma Solutions, an India-based CDMO, in what the CEO said is an "incredibly powerful combination."

DIA 2016

'Now is the time to include Japan' says Parexel

24-Jun-2016 - Japan “welcomes innovation” as it makes significant investments in infrastructure and regulatory changes.

INC Research expands in Japan amid 'evolution of the clinical trial landscape'

30-May-2016 - The CRO has opened new offices in Japan as part of its long-term growth strategy in the country – the world’s second largest pharmaceutical market.

ClinTec 'on track' with growth strategy as new offices open in Spain

26-May-2016 - ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.

Famar set to step into North America by buying Quebec plant from Bayer

18-Apr-2016 - European CDMO Famar says it will continue making products on behalf of Bayer after acquiring a Canadian manufacturing facility from the firm.

Mexico office to bolster CRO Eurotrials' presence in Latin America

17-Mar-2016 - Eurotrials has opened an office in Mexico City in a bid the dominant CRO in the growing Mexican clinical research market.

Eurofins expands into Asia-Pacific through QC services firm acquisition

14-Mar-2016 - Eurofins has bought Australian QC firm ams Laboratories in a push to expand its biopharma testing services into the Asia-Pacific region.

Catalent bringing clinical supply services to Japanese facility

21-Jan-2016 - Catalent will expand its cGMP facility in Japan to bring secondary packaging and clinical supply services to the region.

Exclusive interview

India has 'natural potential to grow' in CRO space, says Syngene CEO

14-Jan-2016 - India’s CRO industry is playing catch-up to the generic and manufacturing sectors, according to the departing CEO of one of the largest players, Syngene.

PRA and newly private WuXi call time on China JV

11-Dec-2015 - WuXi PharmaTech and PRA Health Sciences have ended a three year clinical trial management partnership in China.

Megamerger Pfall-out? $160bn Pfizer-Allergan deal to hit CROs in short-term, analysts

24-Nov-2015 - The $160bn Pfizer-Allergan megamerger could lead to booking cancellations in the short-term say analysts, but CROs – especially Icon, Parexel and PPD - should ultimately benefit.

Recipharm reports 55% sales growth; North America next step in M&A strategy

05-Nov-2015 - Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.

PRA assessing 'underperforming' JV in light of WuXi going private

04-Nov-2015 - Three years on, a joint venture with WuXi Pharmatech is underperforming according to PRA management and could be renegotiated when WuXi goes private.

CROs engaging in a ‘war on talent’, Quintiles CEO says

30-Oct-2015 - The fight between CROs for clinical research associates (CRAs) and people with certain other skillsets is hotting up, with both Icon and Quintiles identifying it as an issue faced by...

Russia's clinical trial approvals 'on the increase'

26-Oct-2015 - The number of clinical trials given the green light in Russia has increased 13% in the third quarter of the year, which could be thanks in part to a reduction...

Indian CMO latest acquisition in Recipharm's aggressive growth push

20-Oct-2015 - An agreement to buy Indian CMO Nitin boosts Recipharm’s presence in emerging markets and plays into its aggressive growth strategy, the firm says.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...